Impact of pegylated interferon alfa-2a treatment on mental health during recent hepatitis C virus infection

BACKGROUND: Pegylated interferon (PEG-IFN) treatment for hepatitis C virus (HCV) infection has neuropsychiatric side effects. Data on the impact of HCV treatment on mental health among injecting drug users (IDUs) are limited. We assessed mental health during treatment of recently acquired HCV, withi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alavi, Maryam, Grebely, Jason, Matthews, Gail V., Petoumenos, Kathy, Yeung, Barbara, Day, Carolyn, Lloyd, Andrew R., Van Beek, Ingrid, Kaldor, John M., Hellard, Margaret, Dore, Gregory J, Haber, Paul S.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3331928/
https://ncbi.nlm.nih.gov/pubmed/22142332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1440-1746.2011.07035.x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares